7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2024-12-31 2024-09-30 2023-12-31 2023-09-30 2022-12-31 2022-09-30 2021-12-31 2021-09-30 2020-12-31 2020-09-30 2019-12-31 2019-09-30 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2016-12-31 2016-09-30 
      
    		                   
      ​
    		                   
      operating activities
    		                   
      net income including noncontrolling interest
    		589,700,000 479,500,000 740,800,000 410,800,000 409,400,000 269,500,000 352,000,000 305,300,000 328,600,000 304,900,000 249,300,000 434,300,000  400,200,000 438,300,000 571,700,000 395,800,000 372,000,000 379,500,000 
      adjustments to reconcile net income to cash from operating activities:
    		                   
      depreciation
    		165,900,000 161,200,000 156,800,000 153,400,000 152,000,000 155,100,000 152,200,000 151,300,000 149,200,000 151,200,000 150,100,000 165,800,000  159,800,000 156,000,000 148,700,000 150,700,000 140,100,000 144,900,000 
      amortization
    		76,600,000 74,300,000 73,300,000 77,100,000 77,400,000 81,400,000 80,600,000 64,300,000 57,700,000 56,300,000 58,900,000 79,000,000  78,100,000 78,600,000 79,100,000 77,600,000 72,500,000 71,900,000 
      deferred income taxes
    		3,600,000 -40,800,000 -12,000,000 -9,800,000 -9,100,000 -36,000,000 -49,000,000 -53,800,000 13,200,000 -29,200,000 8,400,000 -55,400,000  28,500,000 24,000,000 -364,900,000 24,500,000 -35,300,000 -26,500,000 
      share-based compensation expense
    		33,600,000 25,300,000 26,600,000 21,700,000 14,700,000 20,600,000 14,400,000 17,000,000 13,600,000 17,000,000 11,400,000 17,900,000  18,900,000 13,700,000 18,700,000 14,300,000 18,000,000 14,100,000 
      pension and postretirement plan contributions
    		-38,100,000 -10,700,000 -12,900,000 -17,100,000 -63,200,000 -12,500,000 -16,700,000 -8,900,000 -14,800,000 -20,600,000 -16,000,000 -22,000,000  -14,000,000 -12,000,000 -13,100,000 -94,000,000 -4,800,000 -15,000,000 
      pension and postretirement plan income
    		3,500,000 2,800,000 3,500,000 -2,900,000 1,700,000               
      restructuring charges, net of cash paid
    		-17,900,000 35,400,000 -1,800,000 -15,100,000 8,800,000 84,000,000 -4,400,000 -6,600,000 -19,200,000 17,200,000 13,900,000 4,000,000  -13,900,000 63,700,000 -8,100,000 -7,000,000 -12,400,000 -21,000,000 
      sale of global surgical solutions business
    		0                   
      other
    		13,600,000 6,600,000 4,100,000 10,800,000 7,900,000 11,700,000 3,100,000 -3,800,000 7,700,000 16,800,000 -9,600,000 5,300,000  4,000,000 7,700,000 17,500,000 7,300,000 2,300,000 -800,000 
      changes in operating assets and liabilities, net of effect of acquisitions:
    		                   
      accounts receivable
    		-27,900,000 -37,400,000 800,000 4,600,000 -36,100,000 31,200,000 -116,800,000 -77,200,000 -81,900,000 57,100,000 2,400,000 -61,500,000  -2,800,000 -72,800,000 -68,300,000 -39,500,000 -36,900,000 -24,700,000 
      inventories
    		39,300,000 48,000,000 -71,300,000 53,900,000 115,500,000 -17,200,000 -134,900,000 6,800,000 23,700,000 -3,400,000 -24,200,000 88,600,000  30,100,000 -52,300,000 31,400,000 -21,100,000 -15,800,000 -6,000,000 
      other assets
    		11,800,000 16,800,000 -32,000,000 47,000,000 6,000,000 66,800,000 -301,800,000 -44,800,000 5,700,000 64,700,000 26,900,000 60,700,000  -57,800,000 24,200,000 -57,300,000 18,000,000 -20,900,000 -33,700,000 
      accounts payable
    		-55,200,000 22,300,000 67,600,000 13,400,000 19,000,000 134,500,000 96,400,000 128,900,000 38,000,000 44,100,000 -8,300,000 11,300,000  61,300,000 -27,600,000 64,100,000 -27,000,000 -17,500,000 41,600,000 
      other liabilities
    		-7,200,000 -17,600,000 225,900,000 104,700,000 83,700,000 45,100,000 338,400,000 149,900,000 65,500,000 -40,400,000 -99,300,000 80,300,000  126,400,000 16,800,000 252,000,000 76,400,000 -34,700,000 98,000,000 
      cash from operating activities
    		791,300,000 766,700,000 786,700,000 852,500,000 787,700,000 859,200,000 436,700,000 640,900,000 622,700,000 649,800,000 451,800,000 821,000,000  827,300,000 664,700,000 646,400,000 585,200,000 448,000,000 616,900,000 
      investing activities
    		                   
      capital expenditures
    		-261,600,000 -359,700,000 -236,400,000 -262,600,000 -166,500,000 -202,800,000 -192,500,000 -219,200,000 -178,200,000 -126,700,000 -111,700,000 -250,200,000  -213,000,000 -221,600,000 -251,400,000 -198,000,000 -228,800,000 -174,900,000 
      free cash flows
    		529,700,000 407,000,000 550,300,000 589,900,000 621,200,000 656,400,000 244,200,000 421,700,000 444,500,000 523,100,000 340,100,000 570,800,000  614,300,000 443,100,000 395,000,000 387,200,000 219,200,000 442,000,000 
      property and other assets sold
    		4,000,000 8,000,000 -200,000 400,000 900,000 800,000 700,000 -100,000 12,000,000 2,800,000 800,000 2,400,000  500,000 5,000,000 6,600,000 1,600,000 900,000 18,200,000 
      acquisitions and investments in affiliates, net of cash acquired
    		0 -256,500,000 -17,700,000 -73,600,000 -1,800,000 0 0 -3,713,800,000 -120,100,000 0 -200,000 -4,800,000  -152,200,000 500,000 -158,000,000 -4,700,000 -4,800,000 -35,300,000 
      divestiture of businesses, net of cash divested
    		0 0                  
      cash from investing activities
    		-280,600,000 -627,500,000 639,100,000 -348,400,000 -178,600,000 -210,400,000 -195,600,000 -3,941,200,000 -290,700,000 -61,800,000 -173,800,000 -269,900,000  -381,100,000 -204,500,000 -305,100,000 -218,000,000 -247,700,000 -257,900,000 
      financing activities
    		                   
      net issuances of commercial paper and notes payable
    		  1,600,000      1,500,000  -288,900,000    -107,000,000     
      long-term debt borrowings
    		519,000,000       2,481,300,000  0 1,087,000,000     814,400,000  1,596,200,000 0 
      long-term debt repayments
    		 0 -800,000     0  0 -1,270,000,000 0  -249,800,000 -1,200,000 -778,900,000 -14,800,000 -1,439,100,000 -500,000 
      reacquired shares
    		-175,400,000 -2,800,000 -464,300,000 -2,000,000 -800,000 -72,800,000 -42,600,000 -28,800,000 -7,200,000 -21,600,000 -19,900,000 -5,100,000  -241,000,000 -105,600,000 -12,600,000 -86,600,000 -1,800,000 -99,900,000 
      dividends paid
    		-184,400,000 -161,400,000 -162,200,000 -154,700,000 -154,000,000 -157,800,000 -144,900,000 -139,900,000 -139,900,000 -139,000,000 -138,600,000 -136,900,000  -125,700,000 -118,500,000 -118,400,000 -107,400,000 -103,000,000 -106,900,000 
      exercise of employee stock options
    		43,000,000 26,600,000 78,400,000 35,600,000 10,600,000 8,300,000 8,100,000 49,200,000 53,900,000 41,800,000 11,000,000 15,100,000  28,700,000 35,400,000 20,800,000 8,400,000 14,500,000 21,600,000 
      hedge settlements
    		 0 0 38,100,000 100,000 62,400,000 54,200,000             
      cash from financing activities
    		 -140,100,000 -548,300,000 -585,500,000 -147,000,000 -161,700,000 -247,400,000 2,762,500,000 -841,000,000 -370,500,000 -690,300,000 -502,100,000  -353,200,000 -313,000,000 -322,200,000 -426,500,000 -44,800,000 -346,200,000 
      effect of exchange rate changes on cash and cash equivalents
    		1,600,000 -3,400,000 -6,400,000 -400,000 -15,000,000 -1,400,000 -5,700,000 -200,000 4,500,000       -16,800,000 7,700,000 -8,700,000 400,000 
      increase in cash and cash equivalents
    		34,900,000 -4,300,000  -81,800,000    -538,000,000 -504,500,000       2,300,000 -51,600,000 146,800,000 13,200,000 
      cash and cash equivalents, beginning of period
    		0 0 0 0 0 0 0 0 0       0 0 0 0 
      cash and cash equivalents, end of period
    		34,900,000 -4,300,000 877,100,000 -81,800,000 447,100,000 485,700,000 -12,000,000 -538,000,000 -504,500,000       2,300,000 -51,600,000 146,800,000 13,200,000 
      net (repayments) issuances of commercial paper and notes payable
    		   -1,600,000                
      cash used provided by financing activities
    		                   
      net change in cash balances classified as assets held for sale
    		                   
      decrease in cash and cash equivalents
    		                   
      gain on sale of global surgical solutions business
    		 1,000,000                  
      net issuances (repayments) of commercial paper and notes payable
    		                -722,000,000 -84,000,000 -180,000,000 
      supplemental cash flow information
    		                   
      income taxes paid
    		                   
      net interest paid
    		                   
      debt refinancing
    		       0  0          
      less: net income from discontinued operations, including noncontrolling interest
    		                   
      net income from continuing operations, including noncontrolling interest
    		                   
      pension and postretirement plan expense
    		     25,000,000  12,500,000 6,300,000 14,100,000 10,800,000 12,700,000  8,500,000 6,400,000 10,400,000 9,200,000 11,000,000 14,500,000 
      cash from operating activities - continuing operations
    		       640,900,000 622,700,000 649,800,000 451,800,000         
      cash from operating activities - discontinued operations
    		         0 0         
      divestiture of businesses
    		         60,800,000 0 0  0 800,000     
      cash from investing activities - continuing operations
    		       -3,941,200,000 -290,700,000 -61,800,000 -106,200,000         
      cash from investing activities - discontinued operations
    		         0 -67,600,000         
      cash from financing activities - continuing operations
    		       2,762,500,000 -841,000,000 -370,500,000 -690,300,000         
      cash from financing activities - discontinued operations
    		         0 0         
      cash and cash equivalents, beginning of period - continuing operations
    		       0 0           
      cash and cash equivalents, beginning of period - discontinued operations
    		                   
      cash and cash equivalents, end of period - continuing operations
    		       -538,000,000 -504,500,000           
      cash and cash equivalents, end of period - discontinued operations
    		                   
      net issuances (payments) of commercial paper and notes payable
    		                   
      less: net income from discontinued operations including noncontrolling interest
    		         0 0         
      net income from continuing operations including noncontrolling interest
    		       305,300,000 328,600,000 304,900,000 249,300,000         
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		         8,000,000 10,400,000 1,500,000  -2,600,000 2,200,000     
      increase in cash, cash equivalents and restricted cash
    		         225,500,000 -401,900,000         
      cash, cash equivalents and restricted cash, beginning of period - continuing operations
    		         0 0         
      cash, cash equivalents and restricted cash, beginning of period - discontinued operations
    		         0 0         
      cash, cash equivalents and restricted cash, beginning of period
    		         0 0 0  0 0     
      cash, cash equivalents and restricted cash, end of period - continuing operations
    		         225,500,000 -334,300,000         
      cash, cash equivalents and restricted cash, end of period - discontinued operations
    		                   
      cash, cash equivalents and restricted cash, end of period
    		         225,500,000 -334,300,000 50,500,000  90,400,000 149,400,000     
      acquisition related liabilities and contingent consideration
    		          -2,600,000 0  100,000 100,000 -300,000 0 -31,700,000 -400,000 
      gain on sale of businesses
    		                   
      asset charges and write-downs
    		                 15,000,000 0 
      settlement of net investment hedges
    		             0 0     
      acquisition of noncontrolling interests
    		                   
      decrease in cash, cash equivalents and restricted cash
    		              149,400,000     
      excess tax benefits from share-based payment arrangements
    		                 -4,100,000 -19,900,000 
      interest paid
    		                   
      venezuelan charges
    		                   
      (gain) loss on sale of business
    		                   
      capitalized software expenditures
    		               -23,200,000 -17,800,000 -17,200,000 -10,000,000 
      release from (deposit into) acquisition related escrow
    		                   
      reduction of cash due to venezuelan deconsolidation
    		                   
      restricted cash activity
    		               0 0 0  
      net repayments of commercial paper and notes payable
    		                   
      deposit into acquisition related escrow
    		                900,000   
      release from acquisition related escrow
    		                   
      loss on sale of business
    		                   
      adjustments to reconcile net income including noncontrolling interest to cash from operating activities:
    		                   
      restructuring, net of cash paid
    		                   
      (gain) loss on sale of businesses
    		                   
      fixed asset impairment
    		                   
      cash and cash equivalents, beginning of year
    		                   
      cash and cash equivalents, end of year
    		                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.